Trademark: 90904213
Word
SYNNOVATION THERAPEUTICS
Status Date
Thursday, August 8, 2024
Filing Date
Thursday, August 26, 2021
Published for Opposition
Tuesday, July 5, 2022
5 Pharmaceuticals for the treatment of cancer
42 Research and development of pharmaceutical preparations for treatment of cancer; conducting clinical trials for others in the field of drug development for the treatment of cancer; pharmaceutical drug development services focusing on small molecule targeted therapies for the treatment of cancer
Aug 30, 2021
New Application Entered
Oct 12, 2021
New Application Office Supplied Data Entered
May 31, 2022
Assigned To Examiner
Jun 2, 2022
Examiner's Amendment Entered
Jun 2, 2022
Examiners Amendment -Written
Jun 2, 2022
Examiners Amendment E-Mailed
Jun 2, 2022
Notification Of Examiners Amendment E-Mailed
Jun 2, 2022
Approved For Pub - Principal Register
Jun 15, 2022
Notification Of Notice Of Publication E-Mailed
Jul 5, 2022
Published For Opposition
Jul 5, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 9, 2023
Sou Teas Extension Received
Aug 30, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 9, 2023
Sou Extension 1 Filed
Feb 9, 2023
Sou Extension 1 Granted
Jul 27, 2023
Sou Teas Extension Received
Feb 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 8, 2024
Sou Teas Extension Received
Aug 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 8, 2024
Sou Extension 4 Filed
Aug 8, 2024
Sou Extension 4 Granted
Jan 10, 2024
Notice Of Approval Of Extension Request E-Mailed
Jul 27, 2023
Sou Extension 2 Filed
Jul 27, 2023
Sou Extension 2 Granted
Jan 8, 2024
Sou Teas Extension Received
Jan 8, 2024
Sou Extension 3 Filed
Jan 8, 2024
Sou Extension 3 Granted
Trademark Alertz updated from USPTO on 2030-01-24
